News

Is AI changing FDA-biopharma dynamics?
Artificial intelligence is beginning to reshape how drug companies interact with the Food and Drug Administration, though most changes so far have been limited.
Fierce Biotech3d
FDA aims for 'rapid or instant' drug reviews, with AI tool initially assessing applications
The Food and Drug Administration has gone all in on AI since Martin Makary, M.D., took over the agency, most recently ...
FDA Plans to Use AI to Speed Up Drug and Food Safety Reviews
WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) says it plans to use artificial ...
FDA Will Use AI to Approve Drugs and Devices Faster
Learn more about the generative AI technology that will be used at the Food and Drug Administration (FDA) to speed up reviews ...
Futurism on MSN1d
The FDA Is Already Outsourcing Drug and Food Analysis to Error-Plagued AI Chatbot
The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...
FDA to use AI in drug approvals to ‘radically increase efficiency’
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...
FDA plans to use AI to speed drug approvals and review food chemicals under new priorities
Agency’s new road map aims for faster approvals and healthier food, but some experts caution AI is not yet up to the task.
BioSpace3d
Makary, Prasad Lay Out Mission for FDA in Journal Kennedy Called ‘Corrupt’
FDA Commissioner Marty Makary and CBER Director Vinay Prasad published an article in JAMA on Tuesday outlining the FDA’s ...